Library

Aartsma-Rus A, Hegde M, Ben-Omran T, et al. Evidence-Based Consensus and Systematic Review on Reducing the Time to Diagnosis of…

Ishizaki M, Kobayashi M, Adachi K, Matsumura T, Kimura E. Female dystrophinopathy: Review of current literature. Neuromuscular disorders : NMD …

Hollin IL, Peay H, Fischer R, Janssen EM, Bridges JFP. Engaging patients and caregivers in prioritizing symptoms impacting quality of…

Echevarria L, Aupy P, Goyenvalle A. Exon-skipping advances for Duchenne muscular dystrophy. Human molecular genetics  2018;27:R163-R172   Abstract Duchenne muscular…

Batra A, Harrington A, Lott DJ, et al. Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss…

Arora H, Willcocks RJ, Lott DJ, et al. Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.…

Charleston JS, Schnell FJ, Dworzak J, et al. Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production. Neurology…

Mendell JR, Goemans N, Lowes LP, et al. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular…

Mendell JR, Rodino-Klapac LR, Sahenk Z, et al. Eteplirsen for the treatment of Duchenne muscular dystrophy. Annals of neurology 2013;74:637-47…

Salzberg DC, Mann JR, McDermott S. Differences in Race and Ethnicity in Muscular Dystrophy Mortality Rates for Males under 40…